Rekah Pharmaceutical Industry Ltd (REKA) — Free Cash Flow Generation Index
Rekah Pharmaceutical Industry Ltd (REKA) has a Free Cash Flow Generation Index of 0.96x as of June 2026. Free cash flow of ILA13.32 Million represents 1% of operating cash flow (ILA13.82 Million). Explore Rekah Pharmaceutical Industry Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Rekah Pharmaceutical Industry Ltd Free Cash Flow Generation Index (2002–2025)
Historical FCF Generation Index trend for Rekah Pharmaceutical Industry Ltd across 21 annual periods. For the full cash flow conversion analysis, see how efficiently does Rekah Pharmaceutical Industry Ltd generate cash.
Annual Free Cash Flow Generation for Rekah Pharmaceutical Industry Ltd (2002–2025)
Year-by-year Free Cash Flow Generation Index for Rekah Pharmaceutical Industry Ltd. Check Rekah Pharmaceutical Industry Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (ILA) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.46x | ILA5.92 Million | ILA12.95 Million | ILA7.03 Million | ▼ -32.0% |
| 2024 | 0.67x | ILA17.84 Million | ILA26.54 Million | ILA8.70 Million | ▲ +13.0% |
| 2023 | 0.59x | ILA16.86 Million | ILA28.35 Million | ILA11.49 Million | ▼ -26.4% |
| 2022 | 0.81x | ILA31.52 Million | ILA39.00 Million | ILA7.48 Million | ▲ +138.4% |
| 2021 | 0.34x | ILA7.17 Million | ILA21.17 Million | ILA13.99 Million | ▲ +150.6% |
| 2020 | -0.67x | ILA-7.55 Million | ILA11.28 Million | ILA18.84 Million | ▼ -97.6% |
| 2019 | -0.34x | ILA-11.48 Million | ILA33.91 Million | ILA45.40 Million | ▼ -377.7% |
| 2018 | 0.12x | ILA2.11 Million | ILA17.28 Million | ILA15.18 Million | ▼ -60.3% |
| 2017 | 0.31x | ILA7.32 Million | ILA23.80 Million | ILA16.48 Million | ▼ -25.2% |
| 2016 | 0.41x | ILA9.38 Million | ILA22.82 Million | ILA13.44 Million | ▲ +132.5% |
| 2015 | -1.26x | ILA-7.34 Million | ILA5.81 Million | ILA13.15 Million | ▲ +90.6% |
| 2014 | -13.49x | ILA-17.94 Million | ILA1.33 Million | ILA19.27 Million | ▼ -2256.8% |
| 2013 | 0.63x | ILA7.32 Million | ILA11.71 Million | ILA4.38 Million | ▲ +103.3% |
| 2012 | 0.31x | ILA4.36 Million | ILA14.18 Million | ILA9.82 Million | ▼ -85.8% |
| 2010 | 2.17x | ILA14.61 Million | ILA6.73 Million | ILA7.87 Million | ▲ +59.7% |
| 2009 | 1.36x | ILA35.36 Million | ILA26.03 Million | ILA9.33 Million | ▼ -48.4% |
| 2008 | 2.63x | ILA17.30 Million | ILA6.57 Million | ILA10.73 Million | ▲ +84.9% |
| 2007 | 1.42x | ILA17.73 Million | ILA12.45 Million | ILA5.28 Million | ▼ -46.4% |
| 2005 | 2.66x | ILA11.36 Million | ILA4.27 Million | ILA7.09 Million | ▲ +110.5% |
| 2004 | 1.26x | ILA22.57 Million | ILA17.87 Million | ILA4.70 Million | ▲ +3.7% |
| 2002 | 1.22x | ILA13.64 Million | ILA11.21 Million | ILA2.44 Million | — |